Advances in biotechnology: Genomics and genome editing

Genomics, the study of genes, their functions and related techniques has become a crucial science for developing understanding of life processes and how they evolve. Since the advent of the human genome project, huge strides have been made in developing understanding of DNA and RNA sequence informat...

Full description

Bibliographic Details
Main Authors: Gartland Kevan M.A., Dundar Munis, Beccari Tommaso, Magni Mariapia Viola, Gartland Jill S.
Format: Article
Language:English
Published: Sciendo 2017-01-01
Series:The EuroBiotech Journal
Online Access:https://doi.org/10.24190/ISSN2564-615X/2017/01.02
id doaj-63c919ef8419407c908e32e28c4fcb24
record_format Article
spelling doaj-63c919ef8419407c908e32e28c4fcb242021-09-05T17:19:35ZengSciendoThe EuroBiotech Journal2564-615X2017-01-01112910.24190/ISSN2564-615X/2017/01.02Advances in biotechnology: Genomics and genome editingGartland Kevan M.A.0Dundar Munis1Beccari Tommaso2Magni Mariapia Viola3Gartland Jill S.4Life Sciences, Glasgow Caledonian Univsity, Glasgow G4 0BA, United Kingdom of Great Britain and Northern IrelandDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, TurkeyPharmaceutical Sciences, University of Perugia, Perugia, ItalyFondazione Puccinelli, Perugia, ItalyLife Sciences, Glasgow Caledonian Univsity, Glasgow G4 0BA, United Kingdom of Great Britain and Northern IrelandGenomics, the study of genes, their functions and related techniques has become a crucial science for developing understanding of life processes and how they evolve. Since the advent of the human genome project, huge strides have been made in developing understanding of DNA and RNA sequence information and how it can be put to good use in the biotechnology sector. Newly derived sequencing and bioinformatics tools have added to the torrent of new insights gained, so that ‘sequence once and query often’ type DNA apps are now becoming reality. Genome editing, using tools such as CRISPR/Cas9 nuclease or Cpf1 nuclease, provide rapid methods for inserting, deleting or modifying DNA sequences in highly precise ways, in virtually any animal, plant or microbial system. Recent international discussions have considered human germline gene editing, amongst other aspects of this technology. Whether or not gene edited plants will be considered as genetically modified remains an important question. This will determine the regulatory processes adopted by different groups of nations and applicability to feeding the world’s ever growing population. Questions surrounding the intellectual property rights associated with gene editing must also be resolved. Mitochondrial replacement therapy leading to ‘3-Parent Babies’ has been successfully carried out in Mexico, by an international team, to correct mother to child mitochondrial disease transmission. The UK has become the first country to legally allow ‘cautious use’ of mitochondrial donation in treatment. Genomics and genome editing will continue to advance what can be achieved technically, whilst society determines whether or not what can be done should be applied.https://doi.org/10.24190/ISSN2564-615X/2017/01.02
collection DOAJ
language English
format Article
sources DOAJ
author Gartland Kevan M.A.
Dundar Munis
Beccari Tommaso
Magni Mariapia Viola
Gartland Jill S.
spellingShingle Gartland Kevan M.A.
Dundar Munis
Beccari Tommaso
Magni Mariapia Viola
Gartland Jill S.
Advances in biotechnology: Genomics and genome editing
The EuroBiotech Journal
author_facet Gartland Kevan M.A.
Dundar Munis
Beccari Tommaso
Magni Mariapia Viola
Gartland Jill S.
author_sort Gartland Kevan M.A.
title Advances in biotechnology: Genomics and genome editing
title_short Advances in biotechnology: Genomics and genome editing
title_full Advances in biotechnology: Genomics and genome editing
title_fullStr Advances in biotechnology: Genomics and genome editing
title_full_unstemmed Advances in biotechnology: Genomics and genome editing
title_sort advances in biotechnology: genomics and genome editing
publisher Sciendo
series The EuroBiotech Journal
issn 2564-615X
publishDate 2017-01-01
description Genomics, the study of genes, their functions and related techniques has become a crucial science for developing understanding of life processes and how they evolve. Since the advent of the human genome project, huge strides have been made in developing understanding of DNA and RNA sequence information and how it can be put to good use in the biotechnology sector. Newly derived sequencing and bioinformatics tools have added to the torrent of new insights gained, so that ‘sequence once and query often’ type DNA apps are now becoming reality. Genome editing, using tools such as CRISPR/Cas9 nuclease or Cpf1 nuclease, provide rapid methods for inserting, deleting or modifying DNA sequences in highly precise ways, in virtually any animal, plant or microbial system. Recent international discussions have considered human germline gene editing, amongst other aspects of this technology. Whether or not gene edited plants will be considered as genetically modified remains an important question. This will determine the regulatory processes adopted by different groups of nations and applicability to feeding the world’s ever growing population. Questions surrounding the intellectual property rights associated with gene editing must also be resolved. Mitochondrial replacement therapy leading to ‘3-Parent Babies’ has been successfully carried out in Mexico, by an international team, to correct mother to child mitochondrial disease transmission. The UK has become the first country to legally allow ‘cautious use’ of mitochondrial donation in treatment. Genomics and genome editing will continue to advance what can be achieved technically, whilst society determines whether or not what can be done should be applied.
url https://doi.org/10.24190/ISSN2564-615X/2017/01.02
work_keys_str_mv AT gartlandkevanma advancesinbiotechnologygenomicsandgenomeediting
AT dundarmunis advancesinbiotechnologygenomicsandgenomeediting
AT beccaritommaso advancesinbiotechnologygenomicsandgenomeediting
AT magnimariapiaviola advancesinbiotechnologygenomicsandgenomeediting
AT gartlandjills advancesinbiotechnologygenomicsandgenomeediting
_version_ 1717786625506803712